Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TCF3 |
| Upstream (Parents) |
|---|
| (<<) NR1I3 → TCF3 |
| (<<) CUX2 → TCF3 |
| (<<) ONECUT1 → TCF3 |
| (<<) HOXB9 → TCF3 |
| (<<) AR → TCF3 |
| (<<) HOXB6 → TCF3 |
| (<<) NFE2L3 → TCF3 |
| (<<) RXRA → TCF3 |
| Downstream (Children) |
|---|
| TCF3 → TRIM29 (>>) |
| TCF3 → NPAS2 (>>) |
| TCF3 → SIX6 (>>) |
| TCF3 → SIM1 (>>) |
| TCF3 → SOX10 (>>) |
| TCF3 → TBR1 (>>) |
| TCF3 → FOSL1 (>>) |
| TCF3 → FOSL2 (>>) |
| TCF3 → EVX1 (>>) |
| TCF3 → ETV3 (>>) |
| TCF3 → NR1I2 (>>) |
| TCF3 → EGR3 (>>) |
| TCF3 → MSL3 (>>) |
| TCF3 → TAF4B (>>) |
